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a b s t r a c t
Immune adaptors SLP-76, ADAP and SKAP1 (SKAP-55) play central roles in anti-CD3 induced ‘inside-out’
signalling for LFA-1 activation and ICAM-1 adhesion. However, it has been unclear whether SKAP1 is also
required for chemokine-induced T-cell motility. In this study, we found that SDF-1 and CCL21 inducedvailable online 31 October 2009
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-cell migration
similar motility in SKAP1 deﬁcient (SKAP1−/−) and wild type (SKAP1+/+) resting, primary T-cells. In
addition, the speed (i.e. 13M/min), tracking distance (i.e. length) and displacement values (i.e. direct
distance between the start and the end positions of cell movement) in response to SDF1 were similar
for SKAP1−/− and SKAP1+/+ primary, activated T-cells. Relatively high strength anti-CD3 ligation also
arrested the migration (i.e. stop-signal) of resting SKAP1+/+ and SKAP1−/− T-cells in the presence of SDF-
1 and CCL21. These data demonstrate that contrary to its central role in anti-CD3 induced LFA-1 adhesion,
-cellthe response of primary T
. Introduction
Chemokines are chemo-attractants of 7–10kDa that are named
ased on the number and spacing of cysteine residues in the
mino-terminal region as C, CC, CXC or CX3C. They regulate
ultiple cellular functions, including cell adhesion, prolifera-
ion, lymphopoiesis and cell movement to the sites of infection
nd inﬂammation [1]. Upon binding to chemokine receptors,
hemokines generate signals that activate integrins, enabling T-
ells to transmigrate throughhigh endothelial venules (HEVs) lined
n the blood vessel to sites of inﬂammation [2–4].
Integrins are transmembrane adhesion molecules that medi-
te cell–cell or cell–extracellular matrix adhesion. T lymphocytes
xpress mainly 1, 2 and 7 integrins, especially L2 (LFA-
: leukocyte function associated antigen-1) and 41 (VLA-4:
ery late antigen 4). In naïve T-cells, integrins are kept in inac-
ive state, while the T-cell receptor (TCR) can induce ‘inside-out’
ignals that activate integrins, partly due to increased LFA-1 clus-
ering [5–7]. Chemokines can also generate intracellular signals
hat alter the afﬁnity and avidity of LFA-1 function. Chemokines
uch as CCL2, CCL3, CCL4, CXCL10, CXCL9, CCL5, CXCL12 (also
ermed SDF-1, stromal cell-derived factor-1), CCL19, CCL21, CCL20,
CL17 and CCL22 are able to induce the activation of 1, 2 and
7 integrin-dependent adhesion [1]. The arrest in the motility of
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naïve T-cells in HEVs depends on integrins LFA1 and 47 as well
as chemokines CCL21 and CXCL12/SDF-1. Chemokine receptors
are seven-transmembrane-domain G-protein-coupled receptors
(GPCRs) that can be divided into different groups, such that CCR7
binds CCL21 and CXCR4 binds CXCL12/SDF-1 [1].
Several signalling proteins including PI 3K (phosphoinositide
3-kinase) [8], GTPases RhoA [9], protein kinase C [9] and Rap1
[10], as well as the Rap1 ligand RapL (regulator of cell adhesion
and polarisation enriched in lymphoid tissues) [11] play roles in
chemokine signalling for integrin activation and migration. Rap1
andRapLalsoparticipate inanti-CD3 induced ‘inside-out’ signalling
for integrin activation [12,13]. Studies by ourselves and others
have identiﬁed immune cell speciﬁc adaptor proteins ADAP (adhe-
sion anddegranulation-promoting adaptor protein) and SKAP1 (src
kinase-associated phosphoprotein 1: HUGO ofﬁcial designation;
also SKAP-55, src kinase-associated phosphoprotein-55) that posi-
tively regulate TcR induced 1 and 2 integrin activation [14–18].
T-cells from SKAP1−/− mice show defective anti-CD3 induced LFA-
1 clustering despite the presence of intracellular ADAP [17–18].
ADAP binds SKAP1 [19,20] and controls SKAP1 expression levels
in T-cells [21]. One model reported that the ADAP–SKAP1 mod-
ule controls Rap1–GTP membrane localisation [22], while SKAP1
directly interacts with the Rap1–GTP binding partners Riam [23].
In anothermodel, SKAP1expression is needed for anti-CD3 induced
RapL membrane association and Rap1–RapL complex formation
Open access under CC BY license. (unpublished data).
Although ADAP over-expression has been reported to increase
CXCL12/SDF-1 induced cell migration in a Jurkat cell line [24],
it is not known whether SKAP1 plays any role in chemokine-
induced migration of primary T-cells. To address this question,
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e used resting primary T-cells from SKAP1−/− mice to assess
otility in response to CXCL12 andCCL21using dual chamber tran-
well assays. Surprisingly, neither speed nor direct movement to
hemokine gradients was affected by the loss of SKAP1. Unlike in
he case of anti-CD3 induced ‘inside-out’ signalling, SKAP1 is dis-
ensable for both CXCL12 and CCL21 induced T-cell migration.
. Material and methods
.1. Reagents
CXCL12/SDF-1 and CCL21 was purchased from R & D System.
ranswell plates were from Corning incorporated (Costar, Boston,
A, USA). Anti-mouseCXCR4antibody conjugated to FITC and anti-
ouse CD4 conjugated to APC were from BD. Flow-chamber plates
ere ordered from Ibidi (Munich, Germany).
.2. Cell isolation and culture
Spleens were isolated from wild type or SKAP1 deﬁcient mice
eshed through cell strainers, followed by removal of red blood
ells (RBC) with hypotonic buffer (0.15M NH4Cl, 1mM NaHCO3,
.1mM EDTA, PH 7.25). Splenocytes were supplemented with
0% foetal calf serum (FCS), 5% glutamine, 5% Pen-strep and 2-
ercaptoethanol (2-ME) at 5×10−5 M. CD4+ T-cells were puriﬁed
sing mouse anti-CD4 coated Dynal beads (BD Biosciences, Oxford,
K). Alternatively, splenocytes were cultured with Con A (2g/ml)
or 2 days, washed once with growth medium, and cultured with
nterleukin 2 (IL-2; 20ng/ml) for 2–3 days to generate T-cell blasts.
fter washing residual IL-2, T-cells were rested in growth medium
or 2 days, and were then used for experiments.
.3. Chemotaxis assay
Chemokine-induced cell migration was assessed using 5-m
ore size transwells. The membrane inserts were placed in the
ells of a 24-well plate, containing 600l buffer (RPMI with 0.5%
CS) with or without chemokines SDF-1 and CCR27 (100ng/ml).
.2×106 freshly isolated T-cells or splenocytes in 100l buffer
ere loaded into each transwell ﬁlter. After incubation at 37 ◦C
or various time courses, migrated cells to the bottom wells were
ollected and counted.
To measure TcR induced ‘stop’ signal, the membrane inserts
ere pre-coated with anti-CD3 antibodies (5g/ml) with or with-
ut ICAM-1 (5g/ml) for 2h, washed once with PBS, then used for
hemotaxis assay. Alternatively, cells were incubated with solu-
le anti-CD3 (5g/ml) for 10min at 37 ◦C then loaded to transwell
lters. To measure directional cell migration, cells were loaded in
ne well in the ﬂow-chamber plate and chemokines were added in
nother well. Time lapse was used to monitor cell migration in the
iddle area between the two wells. Images were recorded every
s for 120 cycles. Cell tracks were analysed by Velocity Software.
.4. Surface CXCR4 expression levels by ﬂow cytometry
106 restingor anti-CD3 stimulatedWTor SKAP1−/−T-cellswere
ncubated with 2l FITC-conjugated anti-mouse CXCR4 antibody
r isotype control antibody in 200l PBS on ice for 40min followed
y washing once with PBS. The percentage or intensity of CXCR4
taining was analysed by BD FACSCalibur..5. Statistical analysis
Results are given as the mean± standard deviation (S.D.). A
value was tested using unpaired student t-test using Graph-ters 128 (2010) 148–153 149
Pad Prism version 3.02 (GraphPad Software, San Diego, California,
U.S.A.) and p<0.05 was considered as signiﬁcant.
3. Results and discussion
3.1. SKAP1 is dispensable for SDF-1 induced resting T-cell
migration
SKAP1 expression is needed for TcR induced ‘inside-out’ sig-
nalling for integrin activation in T-cells [16–18,22,23]. It has
not been clear whether SKAP1 expression is also needed for
chemokine-induced motility. Previous studies have clearly impli-
cated Rap1–RapL in anti-CD3 and chemokine induced LFA-1
activation [12,13]. To address this, we initially examined whether
SKAP1 could regulate the chemotaxis of resting, primary T-cells
to SDF-1 and CCL21. For this, freshly puriﬁed resting SKAP1+/+
or SKAP1−/− CD4+ T-cells were seeded onto the upper well of a
transwell plate, while SDF-1 was added to the lower well. After
incubation for different times, cells that migrated to the lower well
were counted. An increase in cell number in the lower chamber
was observed over the time course. By 30min, 5–8% of SKAP1+/+
cells had migrated to the lower well that increased to 12–15% by
1h (Fig. 1A and B). After a 3–4-h incubation, the level of migration
reachedaplateauof 40–45%of cells (Fig. 1B). Surprisingly, a compa-
rablenumberofwild typeand SKAP1−/− cellsmigrated to the lower
wells at all time points measured (Fig. 1A and B). To assess whether
differences might become evident in the presence of different con-
centrations of SDF1, a titration was conducted with 1–500ng/ml
of chemokine over an incubation period of 2h. At each concen-
tration, equal numbers of resting SKAP1+/+ and SKAP1−/− T-cells
migrated to the lower chamber (Fig. 1C). Occasionally, SKAP1−/−
T-cells showed a slightly lower level of migration; however, the
difference was less than 10% relative to WT cells and was not
reproducible. Assays were performed in the presence of 0.5% FCS,
although the same results were obtained in the absence of FCS
(data not shown). These data showed that SKAP1 was not needed
for resting T-cell migration to SDF-1 as determined by a transwell
assay.
3.2. SKAP1 is dispensable for SDF-1 induced directional
movement of activated primary T-cells
Given this ﬁnding, we next assessed the movement of activated
primary T-cells using transwell assays. However, this approach
produced a high background migration of activated cells (data
not shown). We therefore attempted to visualise SDF-1 induced
directional T-cell migration on a horizontal interconnected ﬂow
chamber. One well containing T-cells was separated by a septum
connected to another well with SDF-1. This allowed the establish-
ment of a chemokine gradient between wells and the monitoring
of directional cell migration every 5 s for 120 cycles using the
time-lapse microscopy. Some 40% of SKAP1+/+ and SKAP1−/− T-
cellsmigrated towards SDF-1with representative images shown in
Fig. 2A. Velocity software provided anobjectivemeasure ofmotility
showing that both populations of T-cells migrated with an aver-
age speed of 13–15M/min (Fig. 2B). The length (whole distance
following cell tracks) and displacement (direct distance between
the start and the end points of cell movement) was also measured
using the same software (Fig. 2C). Both SKAP1+/+ and SKAP1−/−
T-cells migrated a distance of 140–145M over the time course
and the two populations showed no signiﬁcant difference in the
displacement from the point of origin. These ﬁndings demonstrate
that the absence of SKAP1 does not inﬂuence speed, ormigration to
SDF-1.
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Fig. 1. SKAP1−/− T-cells show normal SDF-1 induced cell migration (A–C). Panel A: Freshly isolated CD4+ T-cells (0.2×106 in 100l RPMI with 0.5% FCS) from SKAP1+/+ and
SKAP1−/− mice were added to the upper wells of the transwell plates and SDF-1 (100ng/ml) was added to lower chambers containing 600l RPMI with 2% FCS. Cells were
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.47 (i.e. 30min), 0.44 (1h) and 0.71 (2h). Panel B: Time course (0–6h) of movem
-cells to different concentrations of SDF1. Different concentrations of SDF-1 were a
ncubation for 2h (P>0.05, when compared SKAP1 KO samples with WT samples).
.3. Anti-CD3 arrests the motility of SKAP1−/− T-cells in the
resence of SDF1Anti-CD3/TCR ligation induces ‘stop-signal’ to arrest T-cell
otility [25], while the co-receptor CTLA-4, that increases LFA1
dhesion, can reverse this event [26]. Similarly, increased adhesion
ia phorbol ester treatment of cells reversed the stop-signal [25].
y contrast, antibodies that increase LFA-1 afﬁnity can arrest cell
ig. 2. SKAP1+/+ and SKAP1−/− activated T-cells migrate at the same speed and distanc
DF-1 was added to another well. Time lapse was used to record cell movement every 5 s
B) and the distance of cell movement (C) were analysed by Velocity software.s were harvested and counted. SKAP1−/− T-cells to WT cells, the P values in (A) are
SKAP1+/+ and SKAP1−/− T-cells to SDF1 in transwell plates. Panel C: Response to
to the bottom wells and cells that migrated to the bottom wells were counted after
movement [25]. The strengthening of adhesion can have opposite
effects on motility depending on whether it is associated with a
concurrent effect on the motility machinery in cells. Our previous
studies showed that anti-CD3 can arrest the majority of SKAP1−/−
T-cells in the absenceof chemokine [27]. Some60%of the SKAP1−/−
T-cells bound weakly to ICAM1 in the absence of SKAP1, while the
remaining population operated in a SKAP1 independent fashion
in binding to ICAM1 [27]. We therefore assessed whether anti-
e in response to SDF1. T-cells were plates in one well in a ﬂow-chamber plate and
for 120 cycles. Representative images at the adjusted time points (A) and motility
H. Wang et al. / Immunology Letters 128 (2010) 148–153 151
Fig. 3. Anti-CD3 stimulation induces ‘stop-signal’ to inhibit SDF-1 or CCL21 induced cell migration in SKAP1−/− T-cells. Panel A: The transwell membrane was coated with
anti-CD3 (5g/ml) in the presence or absence of ICAM-1 (5g/ml) for 2h. After washing once with PBS, WT cells and SKAP1−/− T-cells were seeded to the upper wells and
SDF-1 (100ng/ml) was added to the bottom wells. The number of cells migrated over a 2h period of exposure to medium alone, SDF-1 alone, or a combination of both SDF-1
and 2C11, were collected and counted. The P values are 0.0254 (Medium alone), 0.0877 (SDF-1), 0.1546 (SDF-1+ anti-CD3). Panel B: Fresh or anti-CD3 stimulated WT or
SKAP1 KO CD4+ T-cells were stained with FITC-conjugated anti-CXCR4 and analyzed by FACS. The percentage of CXCR4 positive cells and the mean ﬂuorescence intensity of
CXCR4 staining were provided in the FACS proﬁles. The histogram shows the relative CXCR4 expression levels in anti-CD3 stimulated cells compared to those in resting cells.
Panel C: SKAP1+/+ cells and SKAP1−/− T-cells were seeded in the upper wells and CCL21 (100ng/ml) was added to the bottom wells. Some samples were stimulated with
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Snti-CD3 as described in (A). The number of cells migrated over a 4-h period of exp
ells in response to CCL21.
D3 could arrest the motility of SKAP1−/− T-cells in presence of
DF-1. SDF-1 can directly activate LFA-1 adhesion but has only a
imited ability to reverse the TcR mediated ‘stop-signal’ (i.e. reces-
ive chemokine) [25,28,29]. For this, anti-CD3 was used in plate
ound or soluble form in the presence of ICAM-1. Primary rest-
ng T-cells were loaded on the upper transwell, while the bottom
ell was left untreated or contained SDF-1 (Fig. 3). While SDF1
aused a 5–6-fold increase in the migration of SKAP1+/+ T-cells
o the lower chamber, this response was markedly inhibited by
nti-CD3 treatment in the presence of ICAM-1. Both SKAP1+/+ and
KAP1−/− populations were equally affected by anti-CD3, even in
he presence of chemokine. Anti-CD3 titration from 0.5g/ml to
.0g/ml arrested T-cell migration to SDF-1 in both populations
data not shown). The absence of SKAP1 did therefore not alter the
bility of anti-CD3 to induce the ‘stop-signal’ in the presence of
DF1.
As a control, SKAP1+/+ and SKAP1−/− T-cells were found to
xpress the same level of CXCR4 on resting cell surface (Fig. 3B,
pper FACS proﬁles). Anti-CD3 treatment reduced the expression
evels of CXCR4 to 80% of the untreated control cells in both
-cell populations in terms of the median of ﬂuorescence inten-
ity (MFI) of CXCR4 surface staining (Fig. 3B, right histogram).
here was no signiﬁcant difference in the percentage of CXCR4
ositive SKAP1+/+ and SKAP1−/− T-cells (Fig. 3B, lower proﬁles).
verall, these results indicate that anti-CD3 can arrest T-cell motil-
ty of both SKAP1+/+ and SKAP1−/− T-cells in the presence of
DF-1.were collected and counted. P>0.05 when compared SKAP1−/− cells to SKAP1+/+
3.4. SKAP1 is also not needed for CCL21 induced cell migration of
resting T-cells
CCL21 binding to CCR7 receptor also plays an important
role in T-cell transmigration through blood vessels, migration
in lymph nodes and in T-cell adherence to APCs [1–4]. To
assess the role of SKAP1 in response to this chemokine, CCL21
was similarly added to lower wells of a transwell plate and
assessed for an ability to attract SKAP1+/+ or SKAP1−/− T-cells
(Fig. 3C). After a 4-h incubation, a comparable number of T-
cells from both populations migrated to the bottom well. The
same lack of an effect of SKAP1 deﬁciency was observed at
earlier time points (data not shown). Further, anti-CD3 ligation
blocked SKAP1+/+ or SKAP1−/− T-cell migration in the presence
of a CCL21 gradient (Fig. 3C). These results indicate that SKAP1
is dispensable for CCL21 induced cell migration and cannot
reverse anti-CD3 induced ‘stop’ signal in response to CCL21 gra-
dients.
Our ﬁndings have previously shown a defect in the ‘inside-out’
pathway induced by the TCR in the activation of LFA-1 adhe-
sion in SKAP1−/− T-cells [17,18]. Similar results were obtained
with T-cells from ADAP deﬁcient mice that lack both ADAP and
SKAP1 [18,22,23]. The SLP-76-ADAP module also plays a cen-
tral role in LFA-1 induced ‘outside-in’ signalling leading to T-cell
polarisation and motility [27]. However, a question remained
whether SKAP1 is needed for cell motility induced by chemokines.
There are differences (i.e. adenylate cylases) and similarities (i.e.
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I 3K) in the nature of the signalling pathways employed by
he antigen-receptor and chemokines (SDF-1 and CCL21). Over-
ll, our present ﬁndings showed that the motility of primary
esting and activated T-cells to SDF1 and CCL21 was unaffected
y the absence of SKAP1. This was observed using transwell
lates and time-lapse microscopy. Migration in the transwell assay
equired initial adhesion, as well as the activation of motility
o migrate to the lower chamber. The fact there was no dif-
erence in the number of cells to migrate to the lower well
trongly suggested that sufﬁcient adhesion had been induced in
KAP1−/− T-cells to enable subsequent migration in response to
he chemokine signal. Similarly, tracings of individual cells con-
rmed that the velocity and displacement of activated T-cells
ere the same for SKAP1+/+ and SKAP1−/− T-cells. In some
xperiments, SKAP1−/− T-cells showed 5–10% less migration com-
ared to wild-type cells, however, this minor difference was not
eproducible over the seven experiments that were conducted.
urther, no difference was noted at earlier time points such as
0min or longer periods of incubation (i.e. up to 6h). We can-
ot formally exclude the possibility that there exists a minor
ifference in the overall afﬁnity or avidly of binding to ICAM1
n SKAP1−/− vs. SKAP1+/+ T-cells. However, if a difference does
xist; it has no functional consequence as measured by tran-
well assays and time-lapsemicroscopy. Similar numbers of T-cells
igrated at all times and in response to different concentrations
f SDF1. Therefore, within the limits of the conditions used in
his study, no apparent difference was noted between the two
opulations of T-cells. This does not exclude the possible involve-
ent of SKAP1 in different populations of activated T-cells, or
nder different conditions of adhesion or shear stress. Neverthe-
ess, as an overall effect, it differs markedly from the key role
layed by SKAP1 in TcR induced LFA-1 adhesion in resting T-cells
27].
No difference was also noted in the ability of SKAP1+/+ and
KAP1−/− T-cells to stop in response to TCR ligation in the pres-
nce of chemokine. In this assay, a relatively potent signal was
elivered to T-cells with soluble anti-CD3 or plate bound anti-
D3 prior to the addition of chemokines. One caveat in this assay
s that the subset of primary cells (i.e. >50%) that require SKAP1
xpression for TCR induced adherence to ICAM1 may not have
een fully measured since they would have bound poorly to plates.
urther, T-cells may behave differently in the presence of lower
fﬁnity peptide antigen in the presence of a lymph node environ-
ent.Nevertheless, using theplate assay, the remainingpopulation
f T-cells lacking SKAP1−/− failed to show a difference in their
esponse to SDF1 or CCL21. Since chemokines can localise the
ntermediate afﬁnity of LFA-1 at the leading edge of a migrating
ell [13], and high afﬁnity forms of LFA-1 are located at the bot-
om of cell body [30], one possibility is that while high-avidity
lustering of LFA-1 requires SKAP1, the activation of interme-
iate afﬁnity forms (i.e. induced by chemokines) might sufﬁce
o mediate migration to chemokines and to fail to reverse the
CR stop-signal. In the context of motility, another possibility is
hat chemokines directly activate downstream effectors such as
ap1-RapL without requiring a bridging step provided by SKAP1.
lternatively, it is also possible that the limited expression of
elated family member SKAP2 (SKAP-Hom or SKAP-related) in T-
ells is sufﬁcient to substitute for chemokine, but not TCR induced
esponses, or that ADAP can compensate for SKAP1 in response
o chemokine-induced cell migration. The difference in require-
ent for the adaptor in responses to TCRs and chemokines couldxist to allow for additional junctions of regulation in TCR signalling
uch as the regulation of the extracellular signal-regulated kinase
ERK) regulation [31,32]. Further studieswill be needed to examine
hether SKAP1−/− T-cells migrate normally to the sites of inﬂam-
ation/infection.
[
[ters 128 (2010) 148–153
Acknowledgements
This work was supported by a grant from the Wellcome Trust,
London, United Kingdom (C.E.R. is the recipient of a Principal
Research Fellow Award).
References
[1] LaudannaC,Kim JY, ConstantinG,ButcherE. Rapid leukocyte integrinactivation
by chemokines. Immunol Rev 2002;186:37–46.
[2] Bromley SK, Burack WR, Johnson KG, Somersalo K, Sims TN, Sumen C, et al. The
immunological synapse. Annu Rev Immunol 2001;19:375–96.
[3] Hogg N, Laschinger M, Giles K, McDowall A. T-cell integrins: more than just
sticking points. J Cell Sci 2003;116:4695–705.
[4] GrabovskyV, FeigelsonS, ChenC, BleijsDA, PeledA, CinamonG, et al. Subsecond
induction of alpha4 integrin clustering by immobilized chemokines stimulates
leukocyte tethering and rolling on endothelial vascular cell adhesion molecule
1 under ﬂow conditions. J Exp Med 2002;192:495–506.
[5] Chan JR, Hyduk SJ, Cybulsky MI. Detecting rapid and transient upregulation
of leukocyte integrin afﬁnity induced by chemokines and chemoattractants. J
Immunol Methods 2003;273:43–52.
[6] Kinashi T. Intracellular signalling controlling integrin activation in lympho-
cytes. Nat Rev Immunol 2005;5:546–59.
[7] Luo BH, Carman CV, Springer TA. Structural basis of integrin regulation and
signaling. Annu Rev Immunol 2007;25:619–47.
[8] Sotsios Y, Ward SG. Phosphoinositide 3-kinase: a key biochemical signal
for cell migration in response to chemokines. Immunol Rev 2000;177:217–
35.
[9] Giagulli C, Scarpini E, Ottoboni L, Narumiya S, Butcher EC, Constantin G,
et al. RhoA and zeta PKC control distinct modalities of LFA-1 activation by
chemokines: critical role of LFA-1 afﬁnity triggering in lymphocyte in vivo
homing. Immunity 2004;20:25–35.
10] Shimonaka M, Katagiri K, Nakayama T, Fujita N, Tsuruo T, Yoshie O, et al.
Rap1 translates chemokine signals to integrin activation, cell polarization, and
motility across vascular endothelium under ﬂow. J Cell Biol 2003;161:417–
27.
11] Katagiri K, Ohnishi N, Kabashima K, Iyoda T, Takeda N, Shinkai Y, et al. Crucial
functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell
trafﬁcking. Nat Immunol 2004;5:1045–51.
12] Sebzda E, Bracke M, Tugal T, Hogg N, Cantrell DA. Rap1A positively regulates
T cells via integrin activation rather than inhibiting lymphocyte signaling. Nat
Immunol 2002;3:251–8.
13] Katagiri K, Maeda A, Shimonaka M, Kinashi T. RAPL, a Rap1-binding molecule
that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat
Immunol 2003;4:741–8.
14] Grifﬁths EK, Krawczyk C, Kong YY, Raab M, Hyduk SJ, Bouchard D, et al. Positive
regulation of T cell activation and integrin adhesion by the adapter Fyb/Slap.
Science 2001;293:2260–3.
15] Peterson EJ, Woods ML, Dmowski SA, Derimanov G, Jordan MS, Wu JN,
et al. Coupling of the TCR to integrin activation by Slap-130/Fyb. Science
2001;293:2263–5.
16] Wang H, Moon EY, Azouz A, Wu X, Smith A, Schneider H, et al. SKAP-55 regu-
lates integrin adhesion and formation of T cell–APC conjugates. Nat Immunol
2003;4:366–74.
17] Jo EK, Wang H, Rudd CE. An essential role for SKAP-55 in LFA-1 clustering on
T cells that cannot be substituted by SKAP-55R. J Exp Med 2005;201:1733–
9.
18] Wang H, Liu H, Lu Y, Lovatt M, Wei B, Rudd CE. Functional defects of SKAP-55
deﬁcient T-cells identify a regulatory role for the adaptor in LFA-1 adhesion.
Mol Cell Biol 2007;27:6863–75.
19] Liu J, Kang H, Raab M, da Silva AJ, Kraeft SK, Rudd CE. FYB (FYN binding protein)
serves as a binding partner for lymphoid protein and FYN kinase substrate
SKAP55 and a SKAP55-related protein in T cells. Proc Natl Acad Sci U S A
1998;95:8779–84.
20] Marie-Cardine A, Hendricks-Taylor LR, Boerth NJ, Zhao H, Schraven B, Koretzky
GA. Molecular interaction between the Fyn-associated protein SKAP55 and the
SLP-76-associated phosphoprotein SLAP-130. J Biol Chem 1998;273:25789–
95.
21] Huang Y, Norton DD, Precht P, Martindale JL, Burkhardt JK, Wange RL. Deﬁ-
ciency of ADAP/Fyb/SLAP-130 destabilizes SKAP55 in Jurkat T cells. J Biol Chem
2005;280:23576–83.
22] Kliche S, Breitling D, Togni M, Pusch R, Heuer K, Wang X, et al. The
ADAP/SKAP55 signaling module regulates T-cell receptor-mediated inte-
grin activation through plasma membrane targeting of Rap1. Mol Cell Biol
2006;26:7130–44.
23] Menasche G, Kliche S, Chen EJ, Stradal TE, Schraven B, Koretzky G. RIAM Links
theADAP/SKAP-55signalingmodule toRap1 facilitatingTCR-mediated integrin
activation. Mol Cell Biol 2007;27:4070–81.24] Hunter AJ, Ottoson N, Boerth N, Koretzky GA, Shimizu Y. Cutting edge: a novel
function for the SLAP-130/FYB adapter protein in beta 1 integrin signaling and
T lymphocyte migration. J Immunol 2000;164:1143–7.
25] Dustin ML, Bromley SK, Kan Z, Peterson DA, Unanue DR. Antigen receptor
engagement delivers a stop signal to migrating T lymphocytes. Proc Natl Acad
Sci U S A 1997;94:3909–13.
gy Let
[
[
[
[
[
[31] Schneider H, Wang H, Raab M, Valk E, Smith X, Lovatt M, et al. Adaptor SKAP-
55 binds p21 activating exchange factor RasGRP1 and negatively regulates theH. Wang et al. / Immunolo
26] Schneider H, Downey J, Smith A, Zinselmeyer BH, Rush C, Brewer JM, et al.
Reversal of the TCR stop signal by CTLA-4. Science 2006;313:1972–5.
27] Wang H, Wei B, Rudd CE. SLP-76–ADAP adaptor module regulates LFA-
1 mediated co-stimulation and T-cell motility. Proc Natl Acad Sci U S A
2009;106(30):12436–41.28] Bromley SK, Peterson DA, Gunn MD, Dustin ML. Cutting edge: hierarchy of
chemokine receptor and TCR signals regulating T cell migration and prolifera-
tion. J Immunol 2000;165:15–9.
29] Peacock JW, Jirik FR. TCR activation inhibits chemotaxis toward stromal cell-
derived factor-1: evidence for reciprocal regulation between CXCR4 and the
TCR. J Immunol 1999;162:215–23.
[ters 128 (2010) 148–153 153
30] Stanley P, Smith A, McDowall A, Nicol A, Zicha D, Hogg N. Intermediate-afﬁnity
LFA-1 binds alpha-actinin-1 to control migration at the leading edge of the T
cell. EMBO J 2008;27:62–75.p21-ERK pathway in T-cells. PLoS One 2008;3:e1718.
32] Wang H, Rudd CE. SKAP-55, SKAP-55-related and ADAP adaptors modu-
late integrin-mediated immune-cell adhesion. Trends Cell Biol 2008;18:486–
93.
